Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × FED × Uterine Cervical Dysplasia × Clear all

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Uterine Cervical Dysplasia 1 Ototoxicity 1 Lymphatic Abnormalities 1 Lymphangioma, Cystic 1 Lymphangioma 1 Health Education 1 Colorectal Neoplasms 1 Bowen's Disease 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02130323 2017-06-27

Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

United States Naval Medical Center, San Diego

Phase 2/3 Completed

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡